Accès gratuit
Numéro
Med Sci (Paris)
Volume 30, Numéro 4, Avril 2014
Page(s) 378 - 384
Section Microenvironnements tumoraux : conflictuels et complémentaires
DOI https://doi.org/10.1051/medsci/20143004010
Publié en ligne 5 mai 2014
  1. Bidard FC, Poupon MF. Biologie du processus métastatique. Med Sci (Paris) 2012 ; 28 : 89–95. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  2. Fidler IJ, Kripke ML. Metastasis results from preexisting variant cells within a malignant tumor. Science 1977 ; 197 : 893–895. [CrossRef] [PubMed] [Google Scholar]
  3. Engel J, Eckel R, Kerr J, et al. The process of metastasisation for breast cancer. Eur J Cancer 2003 ; 39 : 1794–1806. [CrossRef] [PubMed] [Google Scholar]
  4. Schmidt-Kittler O, Ragg T, Daskalakis A, et al. From latent disseminated cells to overt metastasis: genetic analysis of systemic breast cancer progression. Proc Natl Acad Sci USA 2003 ; 100 : 7737–7742. [CrossRef] [Google Scholar]
  5. Sola M, Margeli M, Castella E, et al. Prognostic value of hematogenous dissemination and biological profile of the tumor in early breast cancer patients: a prospective observational study. BMC Cancer 2011 ; 11 : 252. [CrossRef] [PubMed] [Google Scholar]
  6. Husemann Y, Geigl JB, Schubert F, et al. Systemic spread is an early step in breast cancer. Cancer Cell 2008 ; 13 : 58–68. [CrossRef] [PubMed] [Google Scholar]
  7. Klein CA. Parallel progression of primary tumours and metastases. Nat Rev Cancer 2009 ; 9 : 302–312. [CrossRef] [PubMed] [Google Scholar]
  8. Damsky WE, Theodosakis N, Bosenberg M. Melanoma metastasis: new concepts and evolving paradigms. Oncogene 2013 ; 3 juin (online). doi : 10.1038/onc.2013.194. [Google Scholar]
  9. Kivela T, Eskelin S, Kujala E. Metastatic uveal melanoma. Int Ophthalmol Clin 2006 ; 46 : 133–149. [CrossRef] [PubMed] [Google Scholar]
  10. Chaturvedi A, Hoffman LM, Welm AL, et al. The EWS/FLI Oncogene drives changes in cellular morphology, adhesion, and migration in Ewing sarcoma. Genes Cancer 2012 ; 3 : 102–116. [CrossRef] [PubMed] [Google Scholar]
  11. Vinokurova S, Wentzensen N, Einenkel J, et al. Clonal history of papillomavirus-induced dysplasia in the female lower genital tract. J Natl Cancer Inst 2005 ; 97 : 1816–1821. [CrossRef] [PubMed] [Google Scholar]
  12. Stoecklein NH, Hosch SB, Bezler M, et al. Direct genetic analysis of single disseminated cancer cells for prediction of outcome and therapy selection in esophageal cancer. Cancer Cell 2008 ; 13 : 441–453. [CrossRef] [PubMed] [Google Scholar]
  13. Eyles J, Puaux AL, Wang X, et al. Tumor cells disseminate early, but immunosurveillance limits metastatic outgrowth, in a mouse model of melanoma. J Clin Invest 2010 ; 120 : 2030–2039. [CrossRef] [PubMed] [Google Scholar]
  14. Rhim AD, Mirek ET, Aiello NM, et al. EMT and dissemination precede pancreatic tumor formation. Cell 2012 ; 148 : 349–361. [CrossRef] [PubMed] [Google Scholar]
  15. Minn AJ, Gupta GP, Siegel PM, et al. Genes that mediate breast cancer metastasis to lung. Nature 2005 ; 436 : 518–524. [CrossRef] [PubMed] [Google Scholar]
  16. Bernards R, Weinberg RA. A progression puzzle. Nature 2002 ; 418 : 823. [CrossRef] [PubMed] [Google Scholar]
  17. Thiery JP, Chua K, Sim WJ, Huang R. La transition épithéliomésenchymateuse au cours du développement dans la fibrose et dans la progression tumorale. Bull Cancer 2010 ; 97 : 1285–1295. [PubMed] [Google Scholar]
  18. De Craene B, Berx G. Regulatory networks defining EMT during cancer initiation and progression. Nat Rev Cancer 2013 ; 13 : 97–110. [CrossRef] [PubMed] [Google Scholar]
  19. Sasaki K, Natsugoe S, Ishigami S, et al. Significance of Twist expression and its association with E-cadherin in esophageal squamous cell carcinoma. J Exp Clin Cancer Res 2009 ; 28 : 158. [CrossRef] [PubMed] [Google Scholar]
  20. Wushou A, Pan HY, Liu W, et al. Correlation of increased twist with lymph node metastasis in patients with oral squamous cell carcinoma. J Oral Maxillofac Surg 2012 ; 70 : 1473–1479. [CrossRef] [PubMed] [Google Scholar]
  21. Bidard FC, Pierga JY, Vincent-Salomon A, Poupon MF. A class action against the microenvironment: do cancer cells cooperate in metastasis?. Cancer Metastasis Rev 2008 ; 27 : 5–10. [CrossRef] [PubMed] [Google Scholar]
  22. Paez-Ribes M, Allen E, Hudock J, et al. Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis. Cancer Cell 2009 ; 15 : 220–231. [CrossRef] [PubMed] [Google Scholar]
  23. Chouaib S, Messai Y, Couve S, et al. Hypoxia promotes tumor growth in linking angiogenesis to immune escape. Front Immunol 2012 ; 3 : 21. [CrossRef] [PubMed] [Google Scholar]
  24. Joyce JA, Pollard JW. Microenvironmental regulation of metastasis. Nat Rev Cancer 2009 ; 9 : 239–252. [CrossRef] [PubMed] [Google Scholar]
  25. Toh B, Wang X, Keeble J, et al. Mesenchymal transition and dissemination of cancer cells is driven by myeloid-derived suppressor cells infiltrating the primary tumor. PLoS Biol 2011 ; 9 : e1001162. [CrossRef] [PubMed] [Google Scholar]
  26. Tomita T, Sakurai Y, Ishibashi S, Maru Y. Imbalance of Clara cell-mediated homeostatic inflammation is involved in lung metastasis. Oncogene 2011 ; 30 : 3429–3439. [CrossRef] [PubMed] [Google Scholar]
  27. Zhang QW, Liu L, Gong CY, et al. Prognostic significance of tumor-associated macrophages in solid tumor: a meta-analysis of the literature. PLoS One 2012 ; 7 : e50946. [CrossRef] [PubMed] [Google Scholar]
  28. Hirshberg A, Leibovich P, Horowitz I, Buchner A. Metastatic tumors to postextraction sites. J Oral Maxillofac Surg 1993 ; 51 : 1334–1337. [CrossRef] [PubMed] [Google Scholar]
  29. Hiratsuka S, Ishibashi S, Tomita T, et al. Primary tumours modulate innate immune signalling to create pre-metastatic vascular hyperpermeability foci. Nat Commun 2013 ; 4 : 1853. [CrossRef] [PubMed] [Google Scholar]
  30. Demicheli R, Retsky MW, Hrushesky WJ, et al. The effects of surgery on tumor growth: a century of investigations. Ann Oncol 2008 ; 19 : 1821–1828. [CrossRef] [PubMed] [Google Scholar]
  31. Strauss DC, Thomas JM. Transmission of donor melanoma by organ transplantation. Lancet Oncol 2010 ; 11 : 790–796. [CrossRef] [PubMed] [Google Scholar]
  32. Kiessling R, Wasserman K, Horiguchi S, et al. Tumor-induced immune dysfunction. Cancer Immunol Immunother 1999 ; 48 : 353–362. [CrossRef] [PubMed] [Google Scholar]
  33. Tatsumi T, Kierstead LS, Ranieri E, et al. Disease-associated bias in T helper type 1 (Th1)/Th2 CD4+ T cell responses against MAGE-6 in HLA-DRB10401+ patients with renal cell carcinoma or melanoma. J Exp Med 2002 ; 196 : 619–628. [CrossRef] [PubMed] [Google Scholar]
  34. Kusmartsev S, Su Z, Heiser A, et al. Reversal of myeloid cell-mediated immunosuppression in patients with metastatic renal cell carcinoma. Clin Cancer Res 2008 ; 14 : 8270–8278. [CrossRef] [PubMed] [Google Scholar]
  35. Luzzi KJ, MacDonald IC, Schmidt EE, et al. Multistep nature of metastatic inefficiency: dormancy of solitary cells after successful extravasation and limited survival of early micrometastases. Am J Pathol 1998 ; 153 : 865–873. [CrossRef] [PubMed] [Google Scholar]
  36. Tsai JH, Donaher JL, Murphy DA, et al. Spatiotemporal regulation of epithelial-mesenchymal transition is essential for squamous cell carcinoma metastasis. Cancer Cell 2012 ; 22 : 725–736. [CrossRef] [PubMed] [Google Scholar]
  37. Malanchi I, Santamaria-Martinez A, Susanto E, et al. Interactions between cancer stem cells and their niche govern metastatic colonization. Nature 2012 ; 481 : 85–89. [CrossRef] [Google Scholar]
  38. Oskarsson T, Massague J. Extracellular matrix players in metastatic niches. EMBO J 2012 ; 31 : 254–256. [CrossRef] [PubMed] [Google Scholar]
  39. Quesnel B. « Je te tiens, tu me tiens »… Dormance tumorale : un équilibre instable ? Med Sci (Paris) 2008 ; 24 : 575–576. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  40. Narang V, Wong SY, Leong SR, et al. Selection of mesenchymal-like metastatic cells in primary tumors: an in silico investigation. Front Immunol 2012 ; 3 : 88. [CrossRef] [PubMed] [Google Scholar]
  41. Ansieau S, Caron de Fromentel C, Bastid J, et al. Rôle de la transition épithéliomésenchymateuse dans la progression tumorale. Bull Cancer 2010 ; 97 : 7–15. [PubMed] [Google Scholar]
  42. Bidard FC, Pierga JY, Soria JC, Thiery JP. Translating metastasis-related biomarkers to the clinic-progress and pitfalls. Nat Rev Clin Oncol 2013 ; 10 : 169–179. [CrossRef] [PubMed] [Google Scholar]
  43. Fridman WH, Sautès-Fridman C. Le microenvironnement tumoral : matrice nourricière, champ de bataille et cible thérapeutique des cancers. Med Sci (Paris) 2014 ; 30 : 359–365. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  44. Provot S. Contrôle de la croissance et de la dissémination tumorales par le microenvironnement : certitudes et hypothèses émergentes. Med Sci (Paris) 2014 ; 30 : 366–371. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  45. Puisieux A, Ansieau S. La dissémination précoce de cellules métastatiques. Med Sci (Paris) 2009 ; 25 : 28–30. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  46. Hasmim M, Messai Y, Zaeem Noman M, Chouaib S. L’hypoxie tumorale : un déterminant clé de la réactivité stromale et de la réponse antitumorale. Med Sci (Paris) 2014 ; 30 : 422–428. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  47. Bruchard M, Ghiringhelli F. Microenvironnement tumoral : cellules régulatrices et cytokines immunosuppressives. Med Sci (Paris) 2014 ; 30 : 429–435. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  48. Azzi A, Gavard J. Vaisseaux sanguins et tumeurs ou l’art du dialogue. Med Sci (Paris) 2014 ; 30 : 408–414. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  49. Galon J, Bindea G, Mlecnik B, et al. Micro-environnement immunitaire et cancer : intérêt de l’immunoscore pour prédire l’évolution clinique. Med Sci (Paris) 2014 ; 30 : 439–444. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.